![](/img/cover-not-exists.png)
Autologous dendritic cell immunotherapy (DCVAC/PCa) added to docetaxel chemotherapy in a Phase III trial (viable) in men with advanced (mCRPC) prostate cancer
Beer, Tomasz M, Vogelzang, Nicholas, Bartůňková, Jiřina, Miller, Kurt, Oh, William, Oudard, Stephane, Pandha, Hardev, Sartor, A Oliver, Špíšek, Radek, Toole, Timothy O, Borgstein, Niels G, Gerritsen,Volume:
3
Year:
2015
Language:
english
Journal:
Journal for ImmunoTherapy of Cancer
DOI:
10.1186/2051-1426-3-S2-P164
File:
PDF, 258 KB
english, 2015